Fundz

Bioxytran, Inc reported raising $250,000 in an initial SEC Form D filing, from an offering of $500,000

PUBLIC · BIXTNov 06, 2018$250K of $500K raised

Amount Raised

$250,000

$250,000 sold, per SEC Form D (first sale Nov 6, 2018)

Round Type

Venture

NeedhamBiotechnology

Quick answer

BIOXYTRAN, INC raised $250,000 in a funding round, dated November 6, 2018. BIOXYTRAN, INC is based in Needham, Massachusetts, United States.

How much did BIOXYTRAN, INC raise?
BIOXYTRAN, INC raised $250,000 in a funding round on November 6, 2018.
What does BIOXYTRAN, INC do?
Developing new drugs under FDA regulation for hypoxia brain and heart ischemia and viral infection like coronavirus and influenza.
Where is BIOXYTRAN, INC based and how big is it?
BIOXYTRAN, INC is based in Needham, Massachusetts, United States.
Who are the decision-makers at BIOXYTRAN, INC?
Fundz holds 1 contact at BIOXYTRAN, INC, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as BIOXYTRAN, INC that raised within 45 days of this round, from Fundz verified event records.

  • Pieces Technologies raised $11M on December 21, 2018.
  • Ionetix Corp raised $27M on December 21, 2018.
  • Prima BioMed Ltd raised $5.2M on December 21, 2018.
  • Axtria raised $12M on December 21, 2018.
  • Vivani Medical, Inc. raised $3M (Seed) on December 21, 2018.
  • Amyris raised $60M on December 21, 2018.

Who to call at BIOXYTRAN, INC, and when

A new round usually means BIOXYTRAN, INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BIOXYTRAN, INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIOXYTRAN, INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIOXYTRAN, INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BIOXYTRAN, INC

Location

75 2ND AVE, SUITE 605

Needham, Massachusetts, United States

About

Developing new drugs under FDA regulation for hypoxia brain and heart ischemia and viral infection like coronavirus and influenza.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BIOXYTRAN, INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsOla S., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BIOXYTRAN, INC's next move

See what Strategic adds

BIOXYTRAN, INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.